Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Calcitonin Gene Related Peptide Type 1 Receptor (CALCRL) also known as the calcitonin receptor-like receptor (CRLR) is a G protein-coupled receptor. It plays an important role in the treatment of migraine.
The CALCRL pipeline market research report provides comprehensive information on the CALCRL targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, the latest news as well as press releases. Additionally, the report provides an overview of key players involved in Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics development with respective active and dormant or discontinued projects.
Key Mechanisms of Action in the CALCRL Pipeline Products Market
The key mechanisms of action in the CALCRL pipeline products market are Calcitonin Gene Related Peptide Type 1 Receptor Antagonist and Calcitonin Gene Related Peptide Type 1 Receptor Agonist.
CALCRL Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights, download a free report sample
Key Routes of Administration in the CALCRL Pipeline Products Market
The key routes of administration in the CALCRL pipeline products market are oral, intravenous, nasal, and subcutaneous.
CALCRL Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights, download a free report sample
Key Molecule Types in the CALCRL Pipeline Products Market
The key molecule types in the CALCRL pipeline products market are small molecule and monoclonal antibody.
CALCRL Pipeline Products Market Analysis by Molecule Types
For more molecule type insights, download a free report sample
Major Companies in the CALCRL Pipeline Products Market
The major companies in the CALCRL pipeline products market are AbbVie Inc, Adepthera LLC, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Modulus Oncology Ltd, and Shanghai Junshi Bioscience Co Ltd.
CALCRL Pipeline Products Market Analysis by Companies
To know more about major companies, download a free report sample
CALCRL Pipeline Products Market Report Overview
Key Mechanisms of Action | Calcitonin Gene Related Peptide Type 1 Receptor Antagonist and Calcitonin Gene Related Peptide Type 1 Receptor Agonist |
Key Routes of Administration | Oral, Intravenous, Nasal, and Subcutaneous |
Key Molecule Type | Small Molecule and Monoclonal Antibody |
Major Companies | AbbVie Inc, Adepthera LLC, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Modulus Oncology Ltd, and Shanghai Junshi Bioscience Co Ltd |
Scope
- The report provides a snapshot of the global therapeutic landscape for Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL)
- The report reviews Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing, and collaboration details & other developmental activities
- The report reviews key players involved in Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics and enlists all their major and minor projects
- The report assesses Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA), and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews the latest news and deals related to Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) targeted therapeutics
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage
- Identify and understand the targeted therapy areas and indications for Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL)
- Identify the use of drugs for target identification and drug repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and their most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Calcitonin Gene Related Peptide Type 1 Receptor (Calcitonin Receptor Like Receptor or CALCRL) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Adepthera LLC
Amgen Inc
Biohaven Pharmaceutical Holding Company Ltd
Modulus Oncology Ltd
Shanghai Junshi Bioscience Co Ltd
Table of Contents
Table
Figures
Frequently asked questions
-
What are the key mechanisms of action in the CALCRL pipeline products market?
The key mechanisms of action in the CALCRL pipeline products market are Calcitonin Gene Related Peptide Type 1 Receptor Antagonist and Calcitonin Gene Related Peptide Type 1 Receptor Agonist.
-
What are the key routes of administration in the CALCRL pipeline products market?
The key routes of administration in the CALCRL pipeline products market are oral, intravenous, nasal, and subcutaneous.
-
What are the key molecule types in the CALCRL pipeline products market?
The key molecule types in the CALCRL pipeline products market are small molecule and monoclonal antibody.
-
Which are the major companies in the CALCRL pipeline products market?
The major companies in the CALCRL pipeline products market are AbbVie Inc, Adepthera LLC, Amgen Inc, Biohaven Pharmaceutical Holding Company Ltd, Modulus Oncology Ltd, and Shanghai Junshi Bioscience Co Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.